DRUG Operating Cash Flow (Statement)
Bright Minds Biosciences Inc · Operating Cash Flow (Statement)
DRUG Operating Cash Flow (Statement)
Latest reported-$25.00M CADperiod ending
DRUG Cash from Operations · CAD (-$42.01K → -$25.00M)
Annual operating cash flow (statement)
High-resolution chart · PNG
DRUG operating cash flow (statement) history
Annual fiscal periods · CAD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (CAD) |
|---|---|
| -8,691,619 | |
| -1,850,186 | |
| -7,024,265 | |
| -13,587,116 | |
| -7,319,301 | |
| -288,392 | |
| -42,009 |